Picture EBD Group World of Partnering Opportunities 650x100px

News > All

Total search results: 3657 | Ordered by Date (descending)
1 2 3 ... 35 36 37  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
High-Tech Gründerfonds Management GmbH. (6/12/24). "Press Release: New component for Germany’s Future Fund – HTGF Opportunity Fund Launches with €660 Million for Growth-phase Investments". 2024-06-12
Tacalyx GmbH. (6/11/24). "Press Release: Tacalyx Extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs". Berlin. 2024-06-11
ITM Isotope Technologies Munich SE. (6/6/24). "Press Release: ITM Raises €188m to Enhance Radiopharmaceutical Pipeline and to Strengthen Leading Position in Medical Radioisotope Manufacturing". Garching. 2024-06-06
Seres Therapeutics, Inc.. (6/6/24). "Press Release: Seres Therapeutics Enters into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science". Cambridge, MA. 2024-06-06
Quantro Therapeutics GmbH. (6/4/24). "Press Release: Quantro Therapeutics Reaches a Milestone in the Collaboration with Boehringer Ingelheim to Develop First-in-Class Cancer Treatments". Vienna. 2024-06-04
PhoreMost Ltd.. (6/3/24). "Press Release: PhoreMost Achieves Second Milestone in Target Discovery Alliance with Boehringer Ingelheim". Cambridge. 2024-06-03
Wacker Chemie AG. (6/3/24). "Press Release: Wacker Opens mRNA Competence Center in Halle an der Saale, Germany". Munich & Halle (Saale). 2024-06-03
Evotec SE. (6/3/24). "Press Release: Evotec and Qiagen Enter Software Collaboration for Enhanced Multi-omics Data Insights". Hamburg & Venlo. 2024-06-03
University of Frankfurt. (6/3/24). "Press Release: Goethe University Frankfurt Founds Institute for Digital Medicine". 2024-06-03
Evotec SE. (5/30/23). "Press Release: Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases". Hamburg. 2024-05-30
BlueRock Therapeutics LP. (5/30/23). "Press Release: BlueRock Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for Parkinson’s Disease Cell Therapy Candidate Bemdaneprocel". Berlin & Cambridge, MA. 2024-05-30
Merck KGaA. (5/29/24). "Press Release: Merck Signs MoU with KAIST to Advance Scientific Collaboration". Darmstadt. 2024-05-29
Fresenius SE & Co. KGaA. (5/29/24). "Press Release: Fresenius Appoints Internationally Experienced Biopharma Expert to the Fresenius Kabi Management Board". 2024-05-29
BioNTech SE. (5/29/24). "Press Release: BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem". Mainz & Oslo. 2024-05-29
BRAIN Biotech AG. (5/29/24). "Press Release: BRAIN Biotech AG Announces the Appointment of Erik de Vries as Senior Business Development Director Enzymes". Zwingenberg & Greifswald. 2024-05-29
ExpressionEdits Ltd.. (5/29/24). "Press Release: ExpressionEdits Raises $13M in Seed Funding to Advance Protein Expression Using AI-Driven Intronization Technology". Cambridge. 2024-05-29
ProBioGen AG. (5/29/24). "Press Release: ModeX Therapeutics Leverages ProBioGen's Expertise for Accelerated COVID-19 Antibody Development". Berlin. 2024-05-29
Numab Therapeutics AG. (5/28/24). "Press Release: Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis". H 2024-05-28
CureVac N.V.. (5/28/24). "Press Release: CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK". Tübingen & Boston, MA. 2024-05-28
TVM Capital Healthcare. (5/28/24). "Press Release: TVM Capital Healthcare Announces the Closing of Its Saudi Arabia-Focused TVM Healthcare Afiyah Fund ". Riyadh. 2024-05-28
Asahi Kasei Corporation. (5/28/24). "Press Release: Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company". 2024-05-28
Origenis GmbH. (5/28/24). "Press Release: OncoBone Ventures and Origenis Announce Partnership to Develop Novel Therapies for Cancer Bone Metastasis". Tübingen & Boston, MA. 2024-05-28
Hitachi High-Tech Corporation. (5/27/24). "Press Release: Roche and Hitachi High-Tech Extend Their Long-standing Partnership". Tokyo. 2024-05-27
Eisbach Bio GmbH. (5/24/24). "Press Release: Eisbach Bio Announces Successful Completion of Phase I Clinical Trial of Nucleic Acid Helicase Inhibitor EIS-10700 with Excellent Safety Properties". Martinsried. 2024-05-24
Daiichi Sankyo Co., Ltd.. (5/22/24). "Press Release: Daiichi Sankyo Establishes Two Research Institutes in the U.S. and EU". 2024-05-22
Merck KGaA. (5/22/24). "Press Release: Merck Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million". Darmstadt. 2024-05-22
Biogen Inc.. (5/22/24). "Press Release: Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences". Cambridge, MA & South San Francisco, CA. 2024-05-22
Refeyn Ltd.. (5/22/24). "Press Release: Refeyn Announces Appointment of Fiona Coats as Chief Marketing Officer". Oxford. 2024-05-22
SixPeaks Bio AG. (5/22/24). "Press Release: SixPeaks Bio AG Debuts With $110 Million in Funding". Basel. 2024-05-22
Jeito Capital. (5/22/24). "Press Release: Jeito Capital Announces Acquisition of Portfolio Company HI-Bio by Biogen Inc. (Nasdaq: BIIB) for up to $1.8 Billion". Paris. 2024-05-22
Captain T Cell GmbH. (5/22/24). "Press Release: Captain T Cell Secures Seed Financing Round Totaling € 8.5 Million". Schönefeld/Berlin. 2024-05-22
Boehringer Ingelheim. (5/22/24). "Press Release: Boehringer Ingelheim and OSE Immunotherapeutics Expand Collaboration to Develop First-in-class Treatments for Cancer and Cardio-renal-metabolic Diseases". Ingelheim & Nantes. 2024-05-22
Cellugy. (5/21/24). "Press Release: Danish Industrial Biotechnology Startup Cellugy Raises €4.9M to Replace Petrochemicals in Personal Care Products". Søborg. 2024-05-21
LabGenius. (5/21/24). "Press Release: LabGenius Raises £35 Million Led by M Ventures to Further Develop Its ML-driven Antibody Discovery Platform and Progress a Pipeline of Assets Towards the Clinic". London. 2024-05-21
Ygion Biomedical GmbH. (5/21/24). "Press Release: Ygion Biomedical Announces €15 Million Series A Financing to Develop Individualized Cancer Immunotherapies". 2024-05-21
Limula SA. (5/21/24). "Press Release: Limula Raises CHF 6.2 Million in Oversubscribed Seed Round to Develop Automated Cell and Gene Therapy Manufacturing Platform". Lausanne. 2024-05-21
Cutiss AG. (5/17/24). "Press Release: Cutiss Announces First Closing of CHF 25M in Series C Funding Round". Switzerland. 2024-05-17
Sartorius AG. (5/16/24). "Press Release: Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with Nvidia". Göttingen. 2024-05-16
Bremen, Senatskanzlei. (5/16/24). "Pressemitteilung: Massenspektrometrie aus Bremen – Bruker Daltonics erweitert Produktion mit zweitem Standort in der Hansestadt". Bremen. 2024-05-16
Molecular Health GmbH. (5/15/24). "Press Release: Integrated DNA Technologies and Molecular Health Ink Commercial Partnership". Coralville, IA & Heidelberg. 2024-05-15
Cell and Gene Therapy Catapult, The. (5/15/24). "Press Release: UK and Swiss Consortium to Apply Innovative Technologies to Lower Cost of Manufacturing Cell and Gene Therapies". London & Zurich. 2024-05-15
Single Use Support GmbH. (5/15/24). "Press Release: Novo Holdings Acquires Majority Stake in Single Use Support". Kufstein. 2024-05-15
NeoSphere Biotechnologies GmbH. (5/14/24). "Press Release: NeoSphere Biotechnologies Partners with Kymera Therapeutics for Novel Molecular Glue Target Discovery". Martinsried. 2024-05-14
H. Lundbeck A/S. (5/13/24). "Press Release: Maria Alfaiate Appointed New Executive Vice President Commercial and Corporate Strategy at Lundbeck". 2024-05-13
AC Immune S.A.. (5/13/24). "Press Release: AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease". Osaka, Cambride, MA & Lausanne. 2024-05-13
ERS Genomics Ltd.. (5/13/24). "Press Release: ERS Genomics Appoints John E Milad as Chief Executive Officer". Stockholm. 2024-05-13
Sartorius AG. (5/13/24). "Press Release: Sartorius Collaborates with Sanofi to Commercialize End-to-end Platform for Downstream process intensification". Göttingen. 2024-05-13
ArgusEye AB. (5/13/24). "Press Release: ArgusEye Closes €2.8 Million Funding to Accelerate Bioprocessing". Stockholm. 2024-05-13
Neurocare Group AG. (5/7/24). "Press Release: Neurocare Group AG Appoints Tariq El-Titi as Senior Vice President MENA, Strengthening Commitment to Middle East Health Sector". Dubai & Munich. 2024-05-07
BioVersys AG. (5/7/24). "Press Release: BioVersys Announces Expansion of Strategic Collaboration with GSK and Extension of its Series C Round by CHF 12.3 Million". Basel. 2024-05-07
Memo Therapeutics AG. (5/7/24). "Press Release: Memo Therapeutics Increases Series C Financing to CHF 45 Million". Schlieren. 2024-05-07
Insempra GmbH. (5/7/24). "Press Release: Insempra Completes $20 Million Financing to Advance the Development of Next-generation Bio-based Ingredients". Munich. 2024-05-07
WhiteLab Genomics. (5/6/24). "Press Release: WhiteLab Genomics Establishes US Presence by Securing Spot at Bayer Co.Lab and Ginkgo Bioworks’ Technology Network". Cambridge, MA. 2024-05-06
Medios AG. (5/6/24). "Press Release: Medios AG – Constantijn van Rietschoten Appointed Executive Board Member for International Markets". Berlin. 2024-05-06
ADC Therapeutics S.A.. (5/6/24). "Press Release: ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants". Lausanne. 2024-05-06
Eisbach Bio GmbH. (5/6/24). "Press Release: Eisbach Bio Announces FDA Clearance of IND Application for EIS-12656, a First-in-Class Allosteric Inhibitor of ALC1". Martinsried. 2024-05-06
Wacker Chemie AG. (5/6/24). "Press Release: Wacker Expands Production Capacity for Biopharmaceuticals in San Diego". Munich & San Diego, CA. 2024-05-06
Topas Therapeutics GmbH. (5/6/24). "Press Release: Topas Therapeutics Appoints Hugo Fry as CEO". Hamburg. 2024-05-06
Mariana Oncology Inc.. (5/2/24). "Press Release: Mariana Oncology to Be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer". Watertown, MA. 2024-05-02
Novartis AG. (5/2/24). "Press Release: Novartis Enters Agreement to Acquire Mariana Oncology, Strengthening Radioligand Therapy Pipeline". Basel. 2024-05-02
PeptiDream Inc.. (4/30/24). "Press Release: PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis". Kanagawa. 2024-04-30
ProBioGen AG. (4/30/24). "Press Release: Change in Management". Berlin. 2024-04-30
Evotec SE. (4/30/24). "Press Release: Bayer and Evotec Collaborate to Advance Precision Cardiology". Berlin & Hamburg. 2024-04-30
General Inception. (4/29/24). "Press Release: General Inception Launches Igniter Europe with the Support of Leading Institutions and Venture Capital Firms". Palo Alto, CA & Lyon. 2024-04-29
Miltenyi Biotec B.V. & Co. KG. (4/29/24). "Press Release: Miltenyi Biotec and MiLaboratories Announce Strategic Partnership to Advance Next-generation Therapies". Bergisch Gladbach & San Francisco, CA. 2024-04-29
Addex Therapeutics S.A.. (4/29/24). "Press Release: Addex Provides Update on ADX71149 Phase 2 Epilepsy Study". Geneva. 2024-04-29
Pfizer Inc.. (4/26/24). "Press Release: U.S. FDA Approves Pfizer’s Beqvez (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B". New York, NY. 2024-04-26
Variantyx, Inc.. (4/26/24). "Press Release: Variantyx Secures $36M Investment as Testing Demand and Market Share Continues to Increase". Framingham, MA. 2024-04-26
Basel Area Business & Innovation. (4/26/24). "Press Release: Johnson & Johnson Opens Innovation Hub in Allschwil". 2024-04-26
Merck KGaA. (4/25/24). "Press Release: Merck Invests More Than € 300 Million in New Life Science Research Center in Germany". Darmstadt. 2024-04-25
CureVac N.V.. (4/24/24). "Press Release: CureVac Appoints Thaminda Ramanayake as New Chief Business Officer". Tübingen & Boston, MA. 2024-04-24
High-Tech Gründerfonds Management GmbH. (4/23/24). "Press Release: Cultimate Foods Raises 2.3 Million EUR Seed Funding from Leading Biotech and Foodtech Investors to Revolutionize the Alternative Meat Industry". Berlin. 2024-04-23
Seamless Therapeutics GmbH. (4/23/24). "Press Release: Seamless Therapeutics Announces New CEO and Board Chairman to Support US Expansion of Programmable Recombinase Gene Editing Technology Platform". Dresden & Lexington, MA. 2024-04-23
Evotec SE. (4/23/24). "Press Release: Evotec SE Appoints Dr Christian Wojczewski as Chief Executive Officer". Hamburg. 2024-04-23
Neurolentech GmbH. (4/22/24). "Press Release: Neurolentech Signs Technology Access Partnership with Kaerus Bioscience to Advance Neurodevelopmental Disorder Research". Klosterneuburg. 2024-04-22
Smart Reporting GmbH. (4/22/24). "Press Release: Smart Reporting Successfully Closes Financing Round for 23 Million Euros". Munich. 2024-04-22
Noscendo GmbH. (4/22/24). "Press Release: Labor Dr. Wisplinghoff Partners with Noscendo – NGS-based Pathogen Diagnostics now an Established Part of Their Service Portfolio". 2024-04-22
Evotec SE. (4/18/24). "Press Release: Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments". Hamburg & Seattle, WA. 2024-04-18
Robert Bosch GmbH. (4/18/24). "Press Release: Additional Partnership in Medical Technology – Bosch and R-Biopharm to Strengthen Vivalytic Analysis platform". Darmstadt, Gerlingen & Waiblingen. 2024-04-18
Outrun Therapeutics Ltd.. (4/18/24). "Press Release: Outrun Therapeutics Launches with a $10m Seed Financing from M Ventures and MP Healthcare Venture Management to Develop a Protein Stabilisation Pipeline". Dundee. 2024-04-18
BioLizard N.V.. (4/18/24). "Press Release: BioLizard Appoints Matthew Hall as Director of Business Development". Lausanne & Ghent. 2024-04-18
Evotec SE. (4/17/24). "Press Release: Evotec Welcomes Aurélie Dalbiez as Chief People Officer". Hamburg. 2024-04-17
Theolytics Ltd.. (4/17/24). "Press Release: Theolytics Successfully Closes Latest Financing Raising Total of £19M ($24.5M) and Welcomes Sound Bioventures as New Investor". Oxford. 2024-04-17
NanoString Technologies, Inc.. (4/17/24). "Press Release: NanoString Technologies to Be Acquired by Bruker Corporation. Bruker Wins Competitive Auction". Seattle, WA. 2024-04-17
CureVac N.V.. (4/16/24). "Press Release: CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines". Tübingen & Houston, TX. 2024-04-16
Roche. (4/11/24). "Press Release: Roche Granted FDA Breakthrough Device Designation for Blood Test to Support Earlier Alzheimer's Disease Diagnosis". Basel. 2024-04-11
FundaMental Pharma GmbH. (4/11/24). "Press Release: FundaMental Pharma Appoints Dr. Dirk Beher as Chief Executive Officer". Heidelberg. 2024-04-11
Asahi Kasei Bioprocess. (4/11/24). "Press Release: Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development". Düsseldorf, Tokyo & New York, NY. 2024-04-11
Idorsia Ltd.. (4/11/24). "Press Release: Idorsia Takes Steps to Address Short-term Liquidity Needs". Allschwil. 2024-04-11
Adrenomed AG. (4/10/24). "Press Release: AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock". Hennigsdorf. 2024-04-10
CRS Clinical Research Services Management GmbH. (4/10/24). "Press Release: CRS Appoints Catherine Canales as New Chief Commercial Officer to Fuel Strategic Development and International Growth". Mannheim. 2024-04-10
Robert Bosch GmbH. (4/10/24). "Press Release: Growth through Medical Technology – Bosch and Randox Invest Heavily in the Vivalytic Analysis Platform". Crumlin, Gerlingen & Waiblingen. 2024-04-10
Sartorius AG. (4/9/24). "Press Release: Sartorius and TheWell Bioscience Partner to Enable more Accurate Predictions in Drug Discovery". Göttingen. 2024-04-09
Green Elephant Biotech GmbH. (4/9/24). "Press Release: Green Elephant Biotech Expands Sustainable 96-well Plate Line for Light-sensitive Experiments". Gießen. 2024-04-09
Prothea Technologies Ltd.. (4/9/24). "Press Release: Prothea Technologies Launches with €12M Series A to Innovate Lung Cancer Diagnosis and Treatment". Edinburgh. 2024-04-09
Boehringer Ingelheim. (4/9/24). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Receives Approval for Supply of EU and US Markets". Ingelheim & Shanghai. 2024-04-09
BioCopy AG. (4/9/24). "Press Release: BioCopy Expands Corporate Portfolio with Acquisition of Perspix Biotech GmbH". Basel. 2024-04-09
Pantherna Therapeutics GmbH / Wacker. (4/5/24). "Press Release: Pantherna and Wacker Intensify Collaboration in the Development and Production of mRNA Biopharmaceuticals". Munich & Hennigsdorf. 2024-04-05
ZAR Real Estate Holding GmbH & Co. KG. (4/5/24). "Press Release: Positive Preliminary Building Permit for “Life Science Campus” in Dusseldorf". Düsseldorf. 2024-04-05
Basilea Pharmaceutica Ltd.. (4/4/24). "Press Release: Basilea Announces US FDA Approval of Antibiotic Zevtara (ceftobiprole medocaril) for Three Indications". Allschwil. 2024-04-04
1 2 3 ... 35 36 37  next pagenext page


Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group World of Partnering Opportunities 650x300px

» top